Varex Imaging (NASDAQ:VREX) Issues Quarterly Earnings Results

Varex Imaging (NASDAQ:VREX) announced its quarterly earnings data on Tuesday. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.18 by $0.19, Zacks reports. Varex Imaging had a positive return on equity of 5.54% and a negative net margin of 16.13%. Varex Imaging updated its Q1 2026 guidance to 0.050-0.250 EPS.

Varex Imaging Trading Up 3.8%

VREX traded up $0.43 during trading on Tuesday, hitting $11.86. The company’s stock had a trading volume of 877,682 shares, compared to its average volume of 424,557. The firm has a market capitalization of $492.19 million, a P/E ratio of -3.69 and a beta of 0.98. Varex Imaging has a twelve month low of $6.76 and a twelve month high of $16.93. The stock’s fifty day moving average price is $11.83 and its 200-day moving average price is $9.82. The company has a quick ratio of 1.82, a current ratio of 3.51 and a debt-to-equity ratio of 0.78.

Institutional Trading of Varex Imaging

Several hedge funds have recently modified their holdings of the stock. The Manufacturers Life Insurance Company lifted its position in shares of Varex Imaging by 10.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 15,302 shares of the company’s stock valued at $133,000 after acquiring an additional 1,442 shares during the period. Comerica Bank increased its stake in Varex Imaging by 9.3% in the third quarter. Comerica Bank now owns 20,363 shares of the company’s stock valued at $253,000 after purchasing an additional 1,726 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in shares of Varex Imaging by 18.5% during the second quarter. BNP Paribas Financial Markets now owns 13,045 shares of the company’s stock valued at $113,000 after purchasing an additional 2,036 shares during the period. Nebula Research & Development LLC boosted its position in shares of Varex Imaging by 11.0% during the 2nd quarter. Nebula Research & Development LLC now owns 22,795 shares of the company’s stock worth $198,000 after purchasing an additional 2,250 shares in the last quarter. Finally, Rhumbline Advisers boosted its position in shares of Varex Imaging by 4.6% during the 2nd quarter. Rhumbline Advisers now owns 61,820 shares of the company’s stock worth $536,000 after purchasing an additional 2,694 shares in the last quarter.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on VREX. B. Riley restated a “buy” rating and set a $16.00 price objective (up from $12.00) on shares of Varex Imaging in a research report on Friday, August 8th. Weiss Ratings reissued a “sell (d)” rating on shares of Varex Imaging in a report on Wednesday, October 8th. Finally, Wall Street Zen downgraded shares of Varex Imaging from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 9th. Two research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $19.50.

Varex Imaging Company Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.